Skip to content
Review

Cannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis.

Oct 2026 · Journal of Affective Disorders · pp. 122588 · 0 citations · 74 references
Medicine

Abstract

Background

Bipolar disorder is a disabling psychiatric condition affecting approximately 2% of the population, for which identifying modifiable risk factors prior to illness onset is a research priority. Cannabis use is highly prevalent, yet its role in the development of bipolar-spectrum outcomes remains unclear. Previous reviews have included few studies or combined distinct bipolar-spectrum outcomes, limiting outcome-specific inference.

Aims

To evaluate the association between cannabis exposure and subsequent incident BD and manic/hypomanic symptoms separately and examine potential moderating factors.

Methods

Registered (https://osf.io/s38x4/), PRISMA/MOOSE-compliant systematic review and meta-analysis of PubMed and Web of Science from inception to October 2025. We included longitudinal observational studies comparing cannabis-exposed and unexposed individuals without prior BD and assessing subsequent bipolar-spectrum outcomes. We meta-analysed studies with extractable data, calculating the unadjusted risk ratios (RRs) for incident BD and manic/hypomanic symptoms. Random-effects meta-analyses, heterogeneity analyses, subgroup analyses and meta-regressions were performed. Study quality was appraised using the Newcastle-Ottawa Scale (NOS).

Results

Nineteen studies were included (total N = 6,960,517; mean age 23.8 ± 11.8 years; 49% female). Cannabis use was associated with increased risk of BD (RR = 2.46, 95% CI = 1.57-3.84; k = 8; N = 206.572) and manic/hypomanic symptoms (RR = 2.11, 95% CI = 1.07-4.18; k = 6; N = 57,243). Moderator analyses identified significant clinical and methodological sources of heterogeneity. NOS scores ranged from 6 to 9, indicating good to high methodological quality.

Conclusion

Cannabis use was associated with an increased risk of subsequent bipolar-spectrum outcomes. Routine evaluation of cannabis use alongside prevention strategies, to delay initiation and reduce use, may warranted.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.